Indefinite Delivery Contract SPE2DR25D9244

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a potential value of up to $4,999,999 and runs through December 2025. Under this contract, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans'...
This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The single-award contract, valued up to $4,999,999, allows the DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which is valid through November 2026, covers an extensive portfolio of branded...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $4,999,999 single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of Department of Defense (DoD) healthcare facilities and veterans' medical centers nationwide. The IDC, valid through December 2036, enables DLA to...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) worth up to $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities worldwide. The IDC, which has a period of performance through December 31, 2036, enables the DLA to issue...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, with a ceiling value of up to $499,999,999 through December 2025. Under this IDC, the DLA issues firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
This is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $499,999,999, allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
The U.S. Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, valid through December 2036, enables DLA to issue firm fixed-price delivery orders for branded and generic...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, which runs through December 2036, covers an extensive...
The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999 IDC, valid through December 2036, enables...

This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $4,999,999.00 and a period of performance through December 31, 2036.

The contract aims to provide the DLA Troop Support Medical Supply Chain with a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. The contract is structured as a firm fixed-price requirements contract, enabling the DLA to issue delivery orders for these pharmaceutical items as needed to meet the medical supply requirements of the Department of Defense and other government agencies. The original solicitation was an unrestricted, fully competitive procurement with the intent to make multiple regional awards to ensure a diversified pharmaceutical supply chain and mitigate risks during contingencies or natural disasters.

Generated 6/6/25, 9:56 AM